KYMR (Kymera Therapeutics) Earnings growth in current year

Official company branding of kymeratx.com (KYMR)

Kymera Therapeutics (KYMR) utilizes an AI platform to develop protein degradation methods that are inaccessible to standard therapies. The annual EPS change step demonstrates profit dynamics, where the value -7.50 describes the current level. Partnerships with pharma behemoths and a broad drug portfolio mitigate risks, although the uncertainty of early clinical trials for PROTAC technologies continues to pressure the company's commercial prospects.

KYMR (Kymera) Earnings growth in current year history from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for Kymera Therapeutics (KYMR)

- business market valuation indicators:
Fundamental valuation:KYMR Kymera Therapeutics Inc
Signature product of Kymera Corp

The development of the TPD platform in immunology and oncology at Kymera Therapeutics (KYMR) directly impacts financial efficiency, as reflected in the year-over-year EPS growth percentages. This indicator measures the rate of change in net income per share, smoothing out volatility and revealing the fundamental undervaluation of the asset, although ignoring operating expenses could lead to overpaying for the stock.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Earnings per share increase in current year|Earnings growth in current year ORIC (ORIC Pharmaceuticals Inc)|Net earnings per share change in current year Relay Pharma|Nurix Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Tyra Biosciences|VSTM (Verastem, Inc.) - Net earnings per share growth this year|GLUE: Net earnings per one share growth for the current year|CGEM (cullinanoncology.com) - Earnings growth in current year|Earnings per share growth rate in current year Immuneering Inc. IMRX|Earnings growth in current year CCCC|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year